200 Pill - blue capsule/oblong, 19mm
Generic Name: hyoscyamine/methenamine/methylene blue/phenyl salicylate/sodium biphosphate
Pill with imprint 200 is Blue, Capsule/Oblong and has been identified as Uro-MP hyoscyamine 0.12 mg /methenamine 118 mg /methylene blue 10 mg /phenyl salicylate 36 mg /sodium phosphate monobasic 40.8 mg. It is supplied by Method Pharmaceuticals, LLC.
Uro-MP is used in the treatment of Urinary Tract Infection and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Uro-MP hyoscyamine 0.12 mg /methenamine 118 mg /methylene blue 10 mg /phenyl salicylate 36 mg /sodium phosphate monobasic 40.8 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 200
Uro-MP
- Generic Name
- hyoscyamine/methenamine/methylene blue/phenyl salicylate/sodium biphosphate
- Imprint
- 200
- Strength
- hyoscyamine 0.12 mg /methenamine 118 mg /methylene blue 10 mg /phenyl salicylate 36 mg /sodium phosphate monobasic 40.8 mg
- Color
- Blue
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Urinary antispasmodics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Method Pharmaceuticals, LLC
- National Drug Code (NDC)
- 58657-0456
- Inactive Ingredients
-
polyethylene glycol,
magnesium stearate,
silicon dioxide,
FD&C Blue No. 1,
FD&C Red No. 3,
titanium dioxide,
gelatin
Note: Inactive ingredients may vary.
Related images for "200"
More about Uro-MP (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Drug class: urinary antispasmodics
- En español
Patient resources
Other brands
Uribel, Phosphasal, Urimar-T, Urelle, ... +15 more
Professional resources
Other brands
Uribel, Phosphasal, Urimar-T, Urelle, ... +8 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.